AI steps in to help detect cancer earlier in beijing men

NCT ID NCT07319923

Summary

This study aims to test a new AI-based early warning system designed to improve how prostate and bladder cancers are found in men. It will involve 3,000 male residents of Beijing aged 50 and older. The goal is to create a better pathway from initial community screening to final diagnosis and treatment, and to see if this model works effectively.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Department of Urology, Peking University First Hospital, Beijing, 100034

    RECRUITING

    Beijing, China

    Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.